There are currently 34 laboratories around the world accredited to conduct human doping control sample analyses. Several other laboratories have expressed interest in entering the WADA accreditation process.
While most WADA-accredited laboratories can also perform blood analyses in support of the heamatological module of the Athlete Biological Passport (ABP), there are currently an additional three approved laboratories (non WADA-accredited laboratories) that are also permitted to conduct such analyses.
WADA accreditation is based upon compliance with two international standards:
- ISO/IEC 17025
- International Standard for Laboratories
For more information on the accreditation process and WADA's EQAS (External Quality Assessment Scheme) process, please consult the International Standard for Larboratories, particularly section 4.0 and Annex A.
WADA publishes, from time to time, specific technical recommendations, addressing particular operational areas of the accredited laboratories, in a Technical Document.
The Technical Documents constitute level-2 elements of the World Anti-Doping Program, and therefore implementation of the technical recommendations described in them is mandatory and must occur by the effective date specified in the Technical Document.
Technical Documents supersede any previous publication on a similar topic, or if applicable, the International Standard for Laboratories. The document in effect is the Technical Document whose effective date most recently precedes that of sample receipt date by the laboratory.
Technical Documents currently in effect (as well as the previous versions) are available for download.
(in alphabetical order)
|Summary of modifications|
|TD2014 DL||TD2014 DL - Summary of Modifications|
|TD2014 EPO||TD2014 EPO - Summary of Modifications|
|TD2015 IDCR||TD2015 IDCR - Summary of Modifications|
|TD2015 MRPL||TD2015 MRPL - Summary of Modifications|
|TD2016 NA||TD2016 NA - Summary of Modifications|
In cooperation with WADA, the International Anti-Doping Agreement (IADA) has also developed guidelines for Anti-Doping Organizations that have already obtained an ISO certification or that wish to be ISO-certified. These are: Guidelines for Transition and Guidelines for Certification.
As with all guidelines under the World Anti-Doping Program, these documents are subject to ongoing review and reassessment.
WADA encourages feedback on the content of the Guidelines, and recommends that stakeholders always consult this Web site for the latest version.
Laboratory Guidelines currently in force:
- Reporting and Management of hCG and LH Findings
- Human Growth Hormone (hGH) Biomarkers Test
- TUE enquiries by Accredited Laboratories
- Laboratory Test Reports
LABORATORY TESTING FIGURES
In accordance with Article 14.5 of the World Anti-Doping Code (the Code), WADA, acting as a central clearinghouse for Doping Control data, annually publishes statistical reports as reported by the WADA accredited laboratories in the Anti-Doping Administration and Management System (ADAMS).
We are pleased to publish the 2013 WADA Anti-Doping Testing Figures Report which includes analyses by the 32 WADA accredited laboratories (in 2013) for in- and out–of-competition Urine, Blood and Blood Passport testing.
WADA has made a number of enhancements to the 2013 report following an internal review, together with feedback received from stakeholders on the 2012 Testing Figures Report. These include:
- sports are now listed along with their disciplines as found in ADAMS;
- sport testing figures are reported only for those sports that are governed by the International Federation who is a signatory to the Code. This includes sports governed by Olympic IFs (including non-Olympic disciplines), IOC Recognised Federations, Non-IOC Recognised Federations, the IPC and other International Federations for athletes with an impairment; and
- the report has been split into a number of separate categories for stakeholders to easily select those specific statistics of interest to them, and combines the Laboratory and ADO testing data in Urine, Blood and Athlete Biological Passport samples.
These enhancements allow for a greater level of detail and accuracy, and make the report more user friendly for those interested in reviewing global anti-doping activity.
It is important to note that the number of Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs) reported by laboratories may not correspond with the number of Anti-Doping Rule Violations (ADRVs) reported by ADOs. This is because all results are subject to a results management process conducted by ADOs, which includes matching results with Therapeutic Use Exemptions (TUEs) and longitudinal studies.
In addition, one single result in the report does not necessarily correspond to one athlete. Results could correspond to multiple findings on the same athlete or measurements performed on the same athlete, such as in the case of longitudinal studies in testosterone.
Collaboration between WADA and the International Laboratory Accreditation Cooperation (ILAC) provides an important opportunity to conduct the International Standard for Laboratories (ISL) assessment concurrently with the ISO/IEC 17025 assessment for the WADA accredited anti-doping laboratories.
The List of ISL Assessors contains the names of the assessors from ILAC-member accreditation bodies trained by WADA for the ISL assessment.